Table 2. Graft use for treatment.
| No treatment | Tigecycline | Mesenchymal stem cell | p | |||
| Median | Interquartile range | Median | Interquartile range | |||
| No Dacron graft implanted | 9.6 (5.3-8.2)x107 | 0 | 0-0 | 0 | 0-0 | <0.001* |
| Dacron graft implanted | - | 81 | 73-86 | 109 | 93-121 | 0.004** |
| The Kruskal-Wallis test median (25-75%); * Difference between treatments in the no graft implantation groups; ** Difference between treatments in the Dacron graft implantation groups. | ||||||